ABBV - FDA snubs AbbVie Parkinson's combo
2024-06-25 09:26:41 ET
AbbVie’s ( NYSE: ABBV ) new drug application for its Parkinson’s disease combination therapy has been denied approval by the FDA ....
FDA snubs AbbVie Parkinson's comboLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get ABBV Alerts
News, Short Squeeze, Breakout and More Instantly...